Point Of Care Diagnostics Market is estimated to be valued at USD 5.13 Bn in 2026 and is expected to reach USD 8.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 5.13 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
6.60% |
2033 Value Projection: |
USD 82 Bn |
Point of care (POC) diagnostics refers to medical diagnostic testing performed outside a laboratory, near or at the site of patient care. Traditionally, most diagnostic tests were conducted in centralized laboratories. However, POC diagnostics helps deliver faster results, enable quick clinical decisions, and provide treatment immediately without transferring samples to distant labs. Technological advancements have enabled the development of portable and easy-to-use devices suitable for near-patient settings like doctor's offices, emergency rooms, pharmacies, and homes. Rising demand for rapid testing and decentralized healthcare, increasing incidence of infectious diseases and growing elderly population susceptible to chronic conditions can drive the global point of care diagnostics market growth.
Market Dynamics
Global point of care diagnostics market growth is driven by factors like growing demand for rapid, convenient and real-time test results, increasing prevalence of chronic and infectious diseases, rising geriatric population worldwide, technological advancements leading to development of user-friendly and portable POC devices. However, lack of infrastructure and skilled professionals in developing nations, high cost of advanced POC devices, and unreliable test results associated with some devices can hamper the market growth. Moreover, untapped opportunities in emerging markets, integration of advanced technologies like AI and IoT with POC devices, and growing applications of POC testing in home healthcare can offer significant opportunities for the market players.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global point of care diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Becton, Dickinson and Company, Johnson & Johnson, Danaher Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global point of care diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global point of care diagnostics market
Market Segmentation
- By Technology Insights (Revenue, USD Bn, 2026 - 2033)
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- Biosensors
- By Application Insights (Revenue, USD Bn, 2026 - 2033)
- Cardio Metabolic Testing
- Infectious Disease Testing
- Nephrology Testing
- Drugs of Abuse (DoA) Testing
- Blood Glucose Testing
- Pregnancy Testing
- Cancer Biomarker Testing
- Others
- By End User Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals
- Diagnostic Laboratories
- Home-Care Settings
- Others
- By Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Siemens Healthineers AG
- Becton, Dickinson and Company
- Qiagen Inc.
- Johnson & Johnson Services, Inc.
- Danaher Corporation (Beckman Coulter Inc.)
- Instrumentation Laboratory
- Nova Biomedical Corporation
- Biomeriux SA
- GE Healthcare
- Philips Healthcare
- Quest Diagnostics
- Fujifilm Medical
- Thermo Fisher Scientific
- Hologic
- Canon
- IDEXX Laboratories
- Sysmex
- QuidelOrtho